ASCO 2024: New ultra-sensitive blood test predicts recurrence of breast cancer, months or even years before relapse 01 Jun 2024 A new type of liquid biopsy test can predict the recurrence of breast cancer in high-risk patients, months or even years before they relapse, research by a team from The Institute of Cancer Research, London, has shown. Find out more Show/Hide
Her Majesty The Queen presents cancer researchers with prize at Buckingham Palace 22 Feb 2024 Earlier today, researchers from The Institute of Cancer Research, London, received a prestigious Queen’s Anniversary Prize on behalf of the institute, in recognition of its transformational breast cancer research programme. Find out more Show/Hide
Blood tests may prevent relapse in breast cancer patients 18 Nov 2022 An innovative trial to detect relapse in breast cancer patients with circulating tumour DNA (ctDNA) has opened at our partner hospital, The Royal Marsden NHS Foundation Trust. The TRAK-ER trial, led by researchers at The Royal Marsden and The Institute of Cancer Research, London, will establish a circulating tumour DNA (ctDNA) surveillance programme for over 1,000 patiets with ER positive breast cancer who are currently receiving hormone therapy to reduce their risk of cancer returning. Find out more Show/Hide
Liquid biopsies one step closer to entering the clinic to help guide breast cancer treatment 01 Nov 2021
Major ‘plasmaMATCH’ trial uses blood test to match women with breast cancer to range of precision treatments 10 Sep 2020
Personalised ‘liquid biopsy’ could detect return of breast cancer nearly eleven months earlier than hospital scans 01 Aug 2019